Clinical Trials Directory

Trials / Completed

CompletedNCT04480398

Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients

A Retrospective Study on Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
Aarogyam UK · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Coronavirus disease 2019 (Covid-19) has been declared global emergency with immediate safety, preventative and curative measures to control the spread of virus. Confirmed cases are treated with clinical management as they are diagnosed but so far, there is no effective treatment or vaccine yet for Covid-19. With recommended guidelines of AYUSH Ministry, India, the use of Ayurveda for Covid-19 has increased; however, its efficacy and safety in Covid-19 confirmed patients remain unclear. Present study examined the efficacy and safety of one of the recommended Ayurveda drug (Guduchi Ghan Vati) compared with standard care for patients with asymptomatic Covid-19 patients.

Conditions

Interventions

TypeNameDescription
DRUGGuduchi Ghan VatiGuduchi Ghan Vati is an Ayuvedic classical preparation which is prepared from aqueous of extract of Tinospora cordifolia.

Timeline

Start date
2020-05-12
Primary completion
2020-06-15
Completion
2020-07-03
First posted
2020-07-21
Last updated
2020-07-22

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04480398. Inclusion in this directory is not an endorsement.